Partner with us
Studies
/
Long-term ketone body therapy of severe multiple acyl-CoA dehydrogenase deficiency: A case report
BHB salts
Human other
2019

Long-term ketone body therapy of severe multiple acyl-CoA dehydrogenase deficiency: A case report

Key finding
The authors conclude that sodium beta-hydroxybutyrate therapy is lifesaving in severe MADD but can have significant adverse effects, and that the tolerable long-term dose was not high enough to notably raise blood beta-hydroxybutyrate.
What the study did

This case report is a retrospective metabolic analysis of a boy with severe multiple acyl-CoA dehydrogenase deficiency treated with sodium beta-hydroxybutyrate from 8 days after birth. After 8 years of standardized therapy with 16 g sodium beta-hydroxybutyrate, substitution with calcium beta-hydroxybutyrate was attempted. Beta-hydroxybutyrate salts caused adverse effects including gastrointestinal discomfort and alkalosis, and measured blood beta-hydroxybutyrate was predominantly 0.1 mmol/L or below or undetectable.

This study used [form], not goBHB. It is shown here as general ketone science. Only goBHB studies back goBHB product claims.
GOBHB//QUERY_CONSOLE271 STUDIES INDEXED
> Ask what it does, which formats it goes into, or who is already using it.
What does BHB do?goBHB in gummies?Who is using goBHB?
Let me put a person on it

A goBHB specialist picks these up and answers inside one business day.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ask
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmaceutical grade, 48 patents, and over 300 million doses in market.
Ask me about goBHB